PRMT5 and prostate carcinoma: PRMT5 physically interacts and forms a complex with p44/MEP40/WD45/WDR77 in various cells, including prostate cancer cells [33], [34], [35], and co-localized with p44 in the cytoplasm of prostate cancer cells (Fig. 1A).